Heparin and pre-menopausal women: increased risk of osteopenia with prolonged use.
|
|
|
Clinical bottom line (level 4)
-
Premenopausal women who took heparin for about half a year were at increased risk of osteopenia.
|
|
Ginsberg et al:
Thrombosis and Haemostasis
1990;
64 (2):
286-289
|
Expires
June 2003
|
The study
Case-control study
with
unblinded, unobjective
outcomes,
not adjusted
for confounding factors,
not
validated in an independent set of patients.
Setting: university hospital, Canada
122 patients
(aged
range 20 to 40 years; mean 30,
100%
female)
pre-menopausal women (56 pregnant)
Excluded if
on chronic corticosteroid therapy
marked obesity (>100 kg)
immobile >1 month
metastatic malignancy
thyrotoxic
hypogonadism
congenital disorders associated with osteopenia
Cases: 61
patients (100% female, mean age 30):
on subcutaneous or intravenous
heparin
(mean dose 25,000 units per day for about 26 weeks)
Controls: 61
patients (100% female, mean age 30):
no heparin
Outcomes studied:
osteopenia
: spine <0.840 g/cm
3
or wrist <0.690 g/cm
3
, diagnosed using: dual photon densitometry of L2 to L4; single photon densitometry of wrist; lateral thoracolumbar film for silent crush fractures
The evidence
Patient expected event rate for osteopenia:
7.75%
| risk factor |
osteopenia present |
osteopenia absent |
unadjusted OR
(95% CI) |
NNH
(% CI) |
| heparin
|
9 |
49 |
inf (3.6 to
inf)
|
|
| no heparin
|
0 |
58 |
- spine bone density g/cm
³
(SD):
- mean difference (95% CI)- 0.037 (-0.012 to 0.086)
- radius bone density g/cm
³
(SD):
- mean difference (95% CI)- 0.003 (-0.038 to 0.032)
Comments
- The study is too small to show any differences in bone density.
Citation
-
Ginsberg
JS,
Kowalchuk
G,
Hirsh
J, et al:
Heparin effect on bone density.
Thrombosis and Haemostasis
1990;
64 (2):
286-289
Contributor: Chris Ball and Clare Wotton,
June 2000
Reviewer:
Clinical Question.
| Patient |
pre-menopausal women |
| Intervention or Exposure |
heparin |
| Outcome |
osteopenia |
|
|